Biomarkers: pros and cons of high-sensitivity assays for cardiac troponin
A 3-h algorithm using high-sensitivity assays for cardiac troponin to rule out myocardial infarction (MI) is recommended in current ESC guidelines. Whether faster rule-out algorithms can discriminate between MI and other conditions that elevate the troponin level, or be safely implemented across the...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
02 October 2012
|
| In: |
Nature reviews. Cardiology
Year: 2012, Volume: 9, Issue: 11, Pages: 616-618 |
| ISSN: | 1759-5010 |
| DOI: | 10.1038/nrcardio.2012.142 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1038/nrcardio.2012.142 Verlag, Volltext: https://www.nature.com/articles/nrcardio.2012.142 
|
| Author Notes: | Evangelos Giannitsis & Hugo A. Katus |
| Summary: | A 3-h algorithm using high-sensitivity assays for cardiac troponin to rule out myocardial infarction (MI) is recommended in current ESC guidelines. Whether faster rule-out algorithms can discriminate between MI and other conditions that elevate the troponin level, or be safely implemented across the whole spectrum of patient risk, is unclear. |
|---|---|
| Item Description: | Gesehen am 08.06.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1759-5010 |
| DOI: | 10.1038/nrcardio.2012.142 |